Insider Transactions in Q4 2022 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2022
|
Benjamin Halladay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+40.83%
|
-
|
|
Oct 18
2022
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
942
-0.86%
|
$6,594
$7.69 P/Share
|
|
Oct 18
2022
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
107
-0.2%
|
$749
$7.69 P/Share
|